Corporate ActionJul 23, 2026, 07:41 PM
Scribe Therapeutics Registers $24.7M Additional Shares for Public Offering
AI Summary
Scribe Therapeutics Inc. has filed an S-1MEF registration statement with the SEC to register an additional $24,667,500 worth of common stock. This filing serves as a post-effective amendment to its previously filed S-1 registration statement (File No. 333-297246), which was declared effective on July 23, 2026. The additional shares are being registered for issuance and sale as part of a public offering, including shares that underwriters have the option to purchase.
Key Highlights
- Filed S-1MEF to register additional shares of common stock for a public offering.
- Additional shares registered are valued at $24,667,500.
- This is an amendment to the prior S-1 registration statement (File No. 333-297246).
- The prior S-1 was declared effective by the SEC on July 23, 2026.
- Scribe Therapeutics is classified as a non-accelerated filer, smaller reporting company, and emerging growth company.
Price Impact
More from SCTX